![Joseph Romano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Romano
Fondatore presso Lucid Psycheceuticals, Inc.
Profilo
Joseph L.
Romano is the founder of Lucid Psycheceuticals, Inc. and Romano Law.
Prior to this, he served as an Independent Director at FSD Pharma, Inc. He completed his undergraduate degree at Osgoode Hall Law School.
Posizioni attive di Joseph Romano
Società | Posizione | Inizio |
---|---|---|
Lucid Psycheceuticals, Inc.
![]() Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Fondatore | - |
Romano Law | Fondatore | - |
Precedenti posizioni note di Joseph Romano
Società | Posizione | Fine |
---|---|---|
FSD PHARMA INC. | Direttore/Membro del Consiglio | - |
Formazione di Joseph Romano
Osgoode Hall Law School | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
FSD PHARMA INC. | Health Technology |
Aziende private | 2 |
---|---|
Lucid Psycheceuticals, Inc.
![]() Lucid Psycheceuticals, Inc. Medical/Nursing ServicesHealth Services Part of FSD Pharma, Inc., Lucid Psycheceuticals, Inc. is a biotech company based in Toronto, CA. Lucid Psycheceuticals was acquired by FSD Pharma, Inc. on September 21, 2021 for $6.64 million. Lucid Psycheceuticals is exploring novel therapies to address total brain health, including mental health disorders and neurodegenerative disorders. The Canadian company has two active pipelines under development and is inspired by the mechanisms of action of psychedelics to prevent and possibly reverse neurodegeneration. The company was founded by Lakshmi P. Kotra and Joseph L. Romano, with Lakshmi P. Kotra serving as the CEO since incorporation. | Health Services |
Romano Law |
- Borsa valori
- Insiders
- Joseph Romano